{"id":"placebo2","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"Placebo2 serves as a comparator in clinical studies to help determine the efficacy of active treatments by controlling for psychological effects and other variables.","oneSentence":"Placebo2 does not have an active pharmacological mechanism; it is designed as a control in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:29:12.472Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05630781","phase":"NA","title":"Orexin s Role in the Neurobiology of Substance Use Disorder","status":"RECRUITING","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2023-02-15","conditions":"Nicotine Dependence","enrollment":140},{"nctId":"NCT03036995","phase":"PHASE2","title":"Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2017-03-20","conditions":"Vitiligo","enrollment":80},{"nctId":"NCT06210854","phase":"PHASE2","title":"Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+","status":"NOT_YET_RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2026-05-01","conditions":"HPV Infection","enrollment":48},{"nctId":"NCT07487909","phase":"PHASE1, PHASE2","title":"A Study of SJP-001 in Comparison With Fexofenadine and Naproxen Administered With Alcohol","status":"COMPLETED","sponsor":"Sen-Jam Pharmaceutical","startDate":"2025-09-30","conditions":"Healthy","enrollment":47},{"nctId":"NCT07207954","phase":"PHASE1","title":"Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Lifordi Immunotherapeutics, Inc.","startDate":"2025-10-06","conditions":"Rheumatoid Arthritis","enrollment":176},{"nctId":"NCT07392372","phase":"PHASE1","title":"A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2026-02-09","conditions":"HIV -1 Infection","enrollment":61},{"nctId":"NCT00856947","phase":"PHASE1","title":"Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood","status":"ACTIVE_NOT_RECRUITING","sponsor":"Copenhagen Studies on Asthma in Childhood","startDate":"2009-03","conditions":"Asthma","enrollment":600},{"nctId":"NCT06966778","phase":"NA","title":"Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2025-09-15","conditions":"Localized Prostate Cancer, Postoperative Urinary Incontinence","enrollment":135},{"nctId":"NCT03947216","phase":"PHASE2","title":"Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.","status":"COMPLETED","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-10-23","conditions":"Parkinson Disease","enrollment":117},{"nctId":"NCT06799000","phase":"PHASE3","title":"A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-01-31","conditions":"Hidradenitis Suppurativa","enrollment":555},{"nctId":"NCT07027800","phase":"NA","title":"High Intensity Resistance Training + Creatine in Perimenopause","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2025-06-02","conditions":"Perimenopause","enrollment":55},{"nctId":"NCT04179175","phase":"PHASE3","title":"Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2020-03-18","conditions":"Hidradenitis Suppurativa","enrollment":703},{"nctId":"NCT06840392","phase":"PHASE3","title":"A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-03-20","conditions":"Hidradenitis Suppurativa","enrollment":555},{"nctId":"NCT06989645","phase":"PHASE1, PHASE2","title":"A Phase 1/2a Study to Evaluate Single Intraarticular Injections of 3 Dose Levels of SYN321 and Placebo in Patients With Symptomatic Knee Osteoarthritis","status":"COMPLETED","sponsor":"Synartro AB","startDate":"2025-08-19","conditions":"Osteoarthritis of Knee","enrollment":35},{"nctId":"NCT05350215","phase":"PHASE1, PHASE2","title":"Atomoxetine and DAW2022 on OSA Severity","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2022-06-01","conditions":"Obstructive Sleep Apnea","enrollment":18},{"nctId":"NCT07444138","phase":"NA","title":"Effects of Beetroot Extract on Blood Pressure and Exercise in Hypertensive Older Women","status":"RECRUITING","sponsor":"São Paulo State University","startDate":"2025-10-08","conditions":"Hypertension, Hypertension (HTN)","enrollment":20},{"nctId":"NCT06047262","phase":"PHASE2","title":"Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia","status":"RECRUITING","sponsor":"Marc Donath","startDate":"2024-07-09","conditions":"Diabetes Mellitus, Type 2","enrollment":300},{"nctId":"NCT03514108","phase":"PHASE4","title":"DANHEART (H-HeFT and Met-HeFT)","status":"COMPLETED","sponsor":"Henrik Wiggers","startDate":"2018-03-01","conditions":"Heart Failure, Diabetes","enrollment":1100},{"nctId":"NCT06954428","phase":"PHASE1","title":"Clinical Trial of Intranasal Delivery of NT-301","status":"COMPLETED","sponsor":"Nano PharmaSolutions Australia","startDate":"2025-06-20","conditions":"Tolerability of NT-301 Nasal Spray, Pharmacokinetics of NT-301 Nasal Spray, Safety of NT-301 Nasal Spray","enrollment":49},{"nctId":"NCT07377409","phase":"NA","title":"Beneficial Effects of Supplementation With CRONILIEF™ (Palmitoylethanolamide Phospholipids) in Diabetic Subjects With Neuropathic Pain.","status":"NOT_YET_RECRUITING","sponsor":"Azienda di Servizi alla Persona di Pavia","startDate":"2026-09-15","conditions":"Neuropathic Pain Management, Diabetic Neuropathies, Painful, Palmitoylethanolamide","enrollment":70},{"nctId":"NCT07169279","phase":"PHASE2","title":"Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)","status":"RECRUITING","sponsor":"QED Therapeutics, a BridgeBio company","startDate":"2025-11-19","conditions":"Achondroplasia","enrollment":77},{"nctId":"NCT05360745","phase":"NA","title":"Quality of Life With Nutritional Supplementation in Patients With Locally Advanced/Metastatic Pancreatic Cancer.","status":"WITHDRAWN","sponsor":"Fundacion para la Excelencia y la Calidad de la Oncologia","startDate":"2022-06-29","conditions":"Quality of Life, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Cancer","enrollment":""},{"nctId":"NCT06331351","phase":"NA","title":"Effect of Jing Si Herbal Tea Liquid Packets on Chronic Pharyngolaryngitis","status":"RECRUITING","sponsor":"Dalin Tzu Chi General Hospital","startDate":"2024-02-22","conditions":"Chronic Pharyngitis","enrollment":120},{"nctId":"NCT02595346","phase":"PHASE2","title":"Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2016-05-17","conditions":"Antiphospholipid Syndrome (APS)","enrollment":25},{"nctId":"NCT07357142","phase":"NA","title":"Jing Si Herbal Tea as Adjuvant Treatment in Patients With Chronic Pelvic Pain Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","startDate":"2026-03-01","conditions":"Chronic Pelvic Pain Syndrome (CPPS)","enrollment":400},{"nctId":"NCT04636814","phase":"PHASE3","title":"A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)","status":"TERMINATED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2021-07-12","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":3973},{"nctId":"NCT06918925","phase":"PHASE1","title":"First-In-Human Study to Evaluate Single and Multiple Ascending Doses of JUV-161 in Healthy Adult Volunteers","status":"RECRUITING","sponsor":"Juvena Therapeutics","startDate":"2025-04-14","conditions":"Healthy Volunteer","enrollment":40},{"nctId":"NCT06600581","phase":"PHASE2","title":"Safety and Efficacy of IMM01-STEM Against Placebo on Muscle Performance in Seniors With Obesity and Muscle Weakness","status":"ACTIVE_NOT_RECRUITING","sponsor":"Immunis, Inc.","startDate":"2024-12-19","conditions":"Muscle Performance, Sarcopenic Obesity","enrollment":55},{"nctId":"NCT05195918","phase":"PHASE1","title":"Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hal Chapman","startDate":"2023-08-24","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":50},{"nctId":"NCT04137107","phase":"PHASE2, PHASE3","title":"Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2020-06-17","conditions":"Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8","enrollment":220},{"nctId":"NCT06265532","phase":"PHASE1","title":"Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hal Chapman","startDate":"2024-02-07","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":22},{"nctId":"NCT03696290","phase":"PHASE4","title":"Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis","status":"TERMINATED","sponsor":"University of Dundee","startDate":"2019-10-19","conditions":"Bronchiectasis Adult","enrollment":34},{"nctId":"NCT07334054","phase":"NA","title":"Effect of Vitamin D and Branched-chain Amino Acids on Physical Performance and Biomarkers of Muscle Fatigue in Runners","status":"NOT_YET_RECRUITING","sponsor":"Pedro Julian Flores Moreno","startDate":"2026-01-01","conditions":"Healthy Adult Male, Runners","enrollment":64},{"nctId":"NCT05988710","phase":"PHASE4","title":"Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-10-19","conditions":"Analgesia, Abuse Opioids, Pain","enrollment":120},{"nctId":"NCT04641143","phase":"PHASE3","title":"Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder","status":"COMPLETED","sponsor":"Biohaven Pharmaceuticals, Inc.","startDate":"2020-12-22","conditions":"Obsessive-Compulsive Disorder","enrollment":456},{"nctId":"NCT07319520","phase":"PHASE2","title":"Clinical Trial to Evaluate the Efficacy and Safety of DW4902","status":"COMPLETED","sponsor":"Daewon Pharmaceutical Co., Ltd.","startDate":"2021-10-06","conditions":"Myoma of Uterus","enrollment":71},{"nctId":"NCT07312110","phase":"PHASE2","title":"D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression","status":"RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2026-01","conditions":"Parkinson s Disease, Parkinson Disease (PD)","enrollment":100},{"nctId":"NCT07059871","phase":"NA","title":"A Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients With Alzheimer's Disease.","status":"RECRUITING","sponsor":"Zhejiang Hospital","startDate":"2025-11-23","conditions":"AD - Alzheimer&#39;s Disease, Sarcopenia, Asthenia","enrollment":200},{"nctId":"NCT06052254","phase":"PHASE2","title":"Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type","status":"RECRUITING","sponsor":"Teikoku Pharma USA, Inc.","startDate":"2025-09-16","conditions":"Agitation","enrollment":150},{"nctId":"NCT06824064","phase":"PHASE2","title":"Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer","status":"RECRUITING","sponsor":"Riboscience, LLC.","startDate":"2025-01-17","conditions":"Metastatic Colorectal Cancer, Advanced Colorectal Cancer","enrollment":150},{"nctId":"NCT03997123","phase":"PHASE3","title":"Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2019-06-25","conditions":"Triple Negative Breast Neoplasms","enrollment":923},{"nctId":"NCT04965298","phase":"PHASE3","title":"Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole","status":"RECRUITING","sponsor":"Norfolk and Norwich University Hospitals NHS Foundation Trust","startDate":"2021-06-16","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":298},{"nctId":"NCT06239116","phase":"PHASE1, PHASE2","title":"A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment","status":"RECRUITING","sponsor":"Rhythm Pharmaceuticals, Inc.","startDate":"2024-03-05","conditions":"Hypothalamic Obesity, Prader-Willi Syndrome, PWS","enrollment":150},{"nctId":"NCT04636801","phase":"PHASE3","title":"A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER)","status":"TERMINATED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2021-07-14","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":4710},{"nctId":"NCT05575492","phase":"PHASE1, PHASE2","title":"A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age","status":"ACTIVE_NOT_RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2022-11-07","conditions":"Cytomegalovirus","enrollment":873},{"nctId":"NCT07279688","phase":"PHASE3","title":"Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Brest","startDate":"2025-12-12","conditions":"Polymyalgia Rheumatica (PMR)","enrollment":140},{"nctId":"NCT05486065","phase":"PHASE2","title":"A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2022-08-08","conditions":"Diabetes Mellitus, Type 2","enrollment":245},{"nctId":"NCT07251023","phase":"PHASE3","title":"Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia","status":"RECRUITING","sponsor":"Bigespas LTD","startDate":"2025-11-20","conditions":"Alzheimer Type Dementia","enrollment":450},{"nctId":"NCT05619653","phase":"PHASE3","title":"Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"Valentina Puentmann","startDate":"2022-12-12","conditions":"COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular","enrollment":279},{"nctId":"NCT06354088","phase":"PHASE1","title":"Human Models of Selective Insulin Resistance: Alpelisib, Part I","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-04-24","conditions":"Insulin Resistance, Prediabetic State, Overweight and Obesity","enrollment":32},{"nctId":"NCT03107884","phase":"EARLY_PHASE1","title":"Role of Metformin on Muscle Health of Older Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2019-08-01","conditions":"Muscle Atrophy, Insulin Resistance","enrollment":64},{"nctId":"NCT06964815","phase":"NA","title":"Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients","status":"RECRUITING","sponsor":"Istituto Oncologico Veneto IRCCS","startDate":"2025-11-12","conditions":"Glioblastoma, IDH Wild-type and STAT3-positive Glioblastoma","enrollment":110},{"nctId":"NCT06107036","phase":"PHASE1","title":"A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-03-06","conditions":"Healthy","enrollment":46},{"nctId":"NCT07252544","phase":"PHASE3","title":"Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-01","conditions":"Stroke, Lacunar, Stroke, Acute Ischemic, Cerebral Small Vessel Diseases","enrollment":3156},{"nctId":"NCT07228338","phase":"EARLY_PHASE1","title":"Cholinergic Enhancement of Theta","status":"NOT_YET_RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2026-01","conditions":"Epilepsy, Seizures, Cognitive Impairment, Mild","enrollment":50},{"nctId":"NCT06207370","phase":"PHASE2","title":"Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis","status":"RECRUITING","sponsor":"60 Degrees Pharmaceuticals LLC","startDate":"2024-06-17","conditions":"Babesiosis","enrollment":33},{"nctId":"NCT05345600","phase":"NA","title":"MILTA vs Placebo Use Comparison for the Management of Pain Related to Perineal Scars Following Delivery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2022-01-31","conditions":"Perineal Scars, Delivery Complication, Episiotomy","enrollment":110},{"nctId":"NCT04355832","phase":"EARLY_PHASE1","title":"Glucagon-like Peptide-1 in Type 1 Diabetes","status":"WITHDRAWN","sponsor":"University of Maryland, Baltimore","startDate":"2020-06-24","conditions":"Type1 Diabetes Mellitus","enrollment":""},{"nctId":"NCT05262270","phase":"PHASE2","title":"Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2023-04-18","conditions":"Cocaine Use Disorder","enrollment":427},{"nctId":"NCT05142267","phase":"NA","title":"Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2022-03-02","conditions":"Opioid Use Disorder, Back Pain, Stress","enrollment":120},{"nctId":"NCT05184569","phase":"PHASE1","title":"Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology","status":"RECRUITING","sponsor":"Peter Ljubenkov, MD","startDate":"2022-04-14","conditions":"Semantic Dementia","enrollment":64},{"nctId":"NCT07209046","phase":"NA","title":"Impact of Probiotic (UltraFlora® Triplebiotic) on Weight Evolution on People After Discontinuation of GLP-1 Treatment.","status":"NOT_YET_RECRUITING","sponsor":"Metagenics, Inc.","startDate":"2025-11-01","conditions":"Adults, GLP-1","enrollment":128},{"nctId":"NCT03228732","phase":"EARLY_PHASE1","title":"The Effects of Fluoxetine and/or DHEA","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2017-12-19","conditions":"Type 1 Diabetes Mellitus","enrollment":60},{"nctId":"NCT05415397","phase":"PHASE3","title":"Treating Immuno-metabolic Depression With Anti-inflammatory Drugs","status":"RECRUITING","sponsor":"Amsterdam UMC, location VUmc","startDate":"2022-09-28","conditions":"Depressive Disorder, Major, Inflammation","enrollment":140},{"nctId":"NCT07206043","phase":"PHASE1","title":"Pharmacokinetics, Safety and Immunogenicity of RPH-104 at a New Dosage and Different Doses Via Single Subcutaneous and Intravenous Administration in Healthy Volunteers","status":"COMPLETED","sponsor":"R-Pharm International, LLC","startDate":"2024-12-03","conditions":"Healthy","enrollment":130},{"nctId":"NCT06128278","phase":"PHASE2","title":"Acute Equol Supplementation and Vascular Function in Women With and Without CKD","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2023-03-07","conditions":"Chronic Kidney Diseases, Vascular Function, Women","enrollment":38},{"nctId":"NCT05126238","phase":"PHASE3","title":"A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction","status":"TERMINATED","sponsor":"Negovsky Reanimatology Research Institute","startDate":"2021-11-20","conditions":"Carotid Artery Diseases, Carotid Artery Stenosis","enrollment":107},{"nctId":"NCT02040298","phase":"PHASE2","title":"Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2014-01","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":50},{"nctId":"NCT04397328","phase":"PHASE3","title":"COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada","status":"WITHDRAWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2020-05-30","conditions":"COVID-19","enrollment":""},{"nctId":"NCT00647166","phase":"PHASE3","title":"Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-05","conditions":"MPA, PAN or EGPA With FFS=0, At Diagnosis or Within the First 15 Days Following Initiation of Corticosteroids","enrollment":114},{"nctId":"NCT07167550","phase":"PHASE3","title":"The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Tatchempharmpreparaty, JSC","startDate":"2025-09-06","conditions":"Stroke, Acute Stroke, Ischemic Stroke","enrollment":184},{"nctId":"NCT03619278","phase":"PHASE1, PHASE2","title":"Evaluating a Combination of Immune-based Therapies to Achieve a Remission of HIV Infection","status":"WITHDRAWN","sponsor":"Judit Pich","startDate":"2020-11-01","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT06826079","phase":"PHASE2, PHASE3","title":"Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-11-01","conditions":"Gastric Junction Adenocarcinoma, Gastric Cancer, Immunotherapy","enrollment":80},{"nctId":"NCT05826782","phase":"NA","title":"Effect of Antioxidant Food Supplement on Sperm Proteomic Structure and Semen Parameters","status":"COMPLETED","sponsor":"Kocaeli University","startDate":"2023-11-30","conditions":"Asthenozoospermia","enrollment":30},{"nctId":"NCT04693351","phase":"PHASE3","title":"Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder","status":"COMPLETED","sponsor":"Biohaven Pharmaceuticals, Inc.","startDate":"2021-01-29","conditions":"Obsessive-Compulsive Disorder","enrollment":589},{"nctId":"NCT07123402","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia","status":"ENROLLING_BY_INVITATION","sponsor":"Beijing Tide Pharmaceutical Co., Ltd","startDate":"2025-04-09","conditions":"Chronic Postoperative Neuralgia","enrollment":184},{"nctId":"NCT05935787","phase":"PHASE3","title":"Cytoflavin in the Complex Rehabilitation of Stroke Patients","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2023-06-09","conditions":"Stroke","enrollment":240},{"nctId":"NCT07121023","phase":"PHASE1","title":"To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic Surgery","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tide Pharmaceutical Co., Ltd","startDate":"2025-08-26","conditions":"Postoperative Analgesia After Unilateral Hallux Valgus Correction Surgery","enrollment":32},{"nctId":"NCT05473039","phase":"NA","title":"Effect of a Multivitamin Supplement With Probiotic (Seidivid Ferty4®) on Oocyte Retrieval and Quality","status":"COMPLETED","sponsor":"SEID S.A.","startDate":"2022-07-11","conditions":"Reproductive Techniques, Assisted","enrollment":196},{"nctId":"NCT07121101","phase":"PHASE2","title":"To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hip Arthroplasty","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tide Pharmaceutical Co., Ltd","startDate":"2025-09-26","conditions":"Postoperative Analgesia After Unilateral Hip Arthroplasty","enrollment":40},{"nctId":"NCT07118930","phase":"PHASE2","title":"Study of Sivelestat Sodium in OPCABG","status":"RECRUITING","sponsor":"Affiliated Hospital of Nantong University","startDate":"2025-08-01","conditions":"Coronary Heart Disease, Coronary Artery Disease, Coronary Arterial Disease (CAD)","enrollment":62},{"nctId":"NCT05801679","phase":"PHASE3","title":"Evaluating Outcomes in Cardiac Surgery Patients Who Receive Sugammadex vs. Placebo","status":"ACTIVE_NOT_RECRUITING","sponsor":"Endeavor Health","startDate":"2023-07-03","conditions":"Surgery","enrollment":175},{"nctId":"NCT06731075","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.","status":"NOT_YET_RECRUITING","sponsor":"Oramed, Ltd.","startDate":"2025-12-15","conditions":"Type 2 Diabetes Mellitus","enrollment":300},{"nctId":"NCT05724069","phase":"PHASE2","title":"Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO).","status":"COMPLETED","sponsor":"Alfasigma S.p.A.","startDate":"2021-12-15","conditions":"Chronic Intestinal Pseudo-obstruction","enrollment":17},{"nctId":"NCT06999577","phase":"PHASE4","title":"The Mechanism Versus PPI Trial","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2025-06-04","conditions":"Laryngopharyngeal Reflux, Cough, Throat Clearing","enrollment":160},{"nctId":"NCT04209218","phase":"NA","title":"Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery","status":"RECRUITING","sponsor":"Peking University First Hospital","startDate":"2020-04-07","conditions":"Lung Cancer, Surgery, Blood Pressure Management","enrollment":1988},{"nctId":"NCT07093697","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212","status":"COMPLETED","sponsor":"Daewon Pharmaceutical Co., Ltd.","startDate":"2024-03-28","conditions":"Acute Bronchitis","enrollment":273},{"nctId":"NCT06932770","phase":"NA","title":"Anti-aging Efficacy of Food Supplement and Cosmetic Routine","status":"COMPLETED","sponsor":"Amazentis SA","startDate":"2025-04-23","conditions":"Aging, Wrinkle","enrollment":72},{"nctId":"NCT05562063","phase":"PHASE4","title":"Sotagliflozin in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients","status":"COMPLETED","sponsor":"Juan Badimon","startDate":"2022-10-26","conditions":"Heart Failure With Preserved Ejection Fraction","enrollment":88},{"nctId":"NCT05064319","phase":"PHASE2","title":"Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2022-02-24","conditions":"Bipolar Disorder, Cannabis Use, Schizoaffective Disorder, Bipolar Type","enrollment":68},{"nctId":"NCT03024775","phase":"NA","title":"Response to Different Wheat Genotypes in Not-celiac Wheat Sensitivity","status":"RECRUITING","sponsor":"University of Palermo","startDate":"2017-01-01","conditions":"Non-celiac Wheat Sensitivity","enrollment":50},{"nctId":"NCT03887624","phase":"EARLY_PHASE1","title":"Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression.","status":"COMPLETED","sponsor":"Zhejiang University","startDate":"2019-05-21","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":16},{"nctId":"NCT06219915","phase":"PHASE1, PHASE2","title":"Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Placebo-Controlled Arm","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2024-03-15","conditions":"Parkinsonian Signs in Older Persons","enrollment":13},{"nctId":"NCT03029689","phase":"PHASE3","title":"Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME STUDY","status":"COMPLETED","sponsor":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","startDate":"2017-07-28","conditions":"HIV","enrollment":61},{"nctId":"NCT06105151","phase":"PHASE1","title":"Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers","status":"RECRUITING","sponsor":"Vigonvita Life Sciences","startDate":"2023-10-27","conditions":"Schizophrenia","enrollment":82},{"nctId":"NCT06008249","phase":"PHASE3","title":"Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)","status":"RECRUITING","sponsor":"Stichting TRICALS Foundation","startDate":"2021-08-09","conditions":"Amyotrophic Lateral Sclerosis","enrollment":171},{"nctId":"NCT03330470","phase":"NA","title":"Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease","status":"COMPLETED","sponsor":"Slovak Academy of Sciences","startDate":"2017-01-01","conditions":"Subjective Cognitive Impairment, Mild Cognitive Impairment, Parkinson Disease","enrollment":26},{"nctId":"NCT04007289","phase":"PHASE3","title":"Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-06-24","conditions":"Intrahepatic Non Cirrhotic Portal Hypertension","enrollment":166},{"nctId":"NCT06676774","phase":"PHASE2","title":"Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-05-16","conditions":"Arginine Vasopressin Deficiency, Diabetes Insipidus","enrollment":42},{"nctId":"NCT06898476","phase":"NA","title":"Silkworm Pupa Powder Improves Dementia.","status":"RECRUITING","sponsor":"Zhejiang Provincial Tongde Hospital","startDate":"2025-04-10","conditions":"Alzheimer Disease(AD), Sarcopenia, Asthenia","enrollment":300}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo2","genericName":"Placebo2","companyName":"Innovent Biologics (Suzhou) Co. Ltd.","companyId":"innovent-biologics-suzhou-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}